PD-1 Axis Inhibitors in EGFR- and ALK-Driven Lung Cancer: Lost Cause? [electronic resource]
Producer: 20180112Description: 4539-41 p. digitalISSN:- 1557-3265
- Anaplastic Lymphoma Kinase
- Antineoplastic Agents -- pharmacology
- ErbB Receptors -- genetics
- Gene Rearrangement
- Humans
- Lung Neoplasms -- drug therapy
- Molecular Targeted Therapy
- Mutation
- Programmed Cell Death 1 Receptor -- antagonists & inhibitors
- Receptor Protein-Tyrosine Kinases -- genetics
- Tumor Microenvironment -- drug effects
No physical items for this record
Publication Type: Letter
There are no comments on this title.
Log in to your account to post a comment.